Results 181 to 190 of about 117,497 (280)
Decoding the Oncogenic Role of USP22 Through Pan‐Cancer Genomic and Epigenetic Analysis
ABSTRACT Background Ubiquitin‐specific protease 22, an important catalytic component of the human SAGA (Spt‐Ada‐GcN5 Acetyltransferase) complex, regulates the deubiquitination and methylation of histones, which in turn influences gene expression. Its overexpression alters gene regulation, transcription, cancer progression, and therapy resistance.
Uma Devi A., Prakash Kumar Shukla
wiley +1 more source
A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP-ALL uncovers novel therapeutic targets. [PDF]
Malouf C +13 more
europepmc +1 more source
Abstract Murine competitive congenic bone marrow transplantation is an important method used to identify genetic contributions to immune cell abundance, activation, differentiation, and mobilization, either in the bone marrow or in the peripheral organs of the host.
Vinicius Canale +5 more
wiley +1 more source
Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. [PDF]
Hanna C +4 more
europepmc +1 more source
• XPO1 hyperactivation promotes leukaemogenesis by altering nucleocytoplasmic transport and transcriptional control in acute myeloid leukaemia (AML). • Selinexor and eltanexor show preferential activity in NPM1‐mutated, DEK::NUP214‐positive and SF3B1‐mutated myeloid neoplasms.
Yifan Liu +4 more
wiley +1 more source
Remethylation of Dnmt3a−/− hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewing [PDF]
Bangert, Celia V. +17 more
core +1 more source
Dendritic cells in hematologic malignancies: a brief review of immunoregulation to new perspectives. [PDF]
de Almeida GB +6 more
europepmc +1 more source
Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia.
A. Tobler +6 more
semanticscholar +1 more source
ABSTRACT Glioblastoma (GBM) remains one of the most lethal brain malignancies because of its highly immunosuppressive tumor microenvironment and the limited penetration of therapeutics across the blood‐brain barrier (BBB). Although recent studies have separately explored STING agonism, microglial reprogramming, and nanocarrier‐based drug delivery, an ...
Mohamed S. Nafie +2 more
wiley +1 more source

